BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 26645730)

  • 1. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.
    Chang LW; Kazlouskaya V; Kazi R; Davar D; Ferris RL; Ho J; Karunamurthy A; Jedrych JJ; Bunimovich YL
    Am J Dermatopathol; 2020 Nov; 42(11):854-857. PubMed ID: 32310862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
    Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
    J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
    Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
    Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases.
    Goto K; Pissaloux D; Paindavoine S; Tirode F; de la Fouchardière A
    Am J Surg Pathol; 2019 Oct; 43(10):1368-1376. PubMed ID: 31162285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma.
    Chen PL; Neishaboori N; Tetzlaff MT; Chen WS; Aung PP; Curry JL; Nagarajan P; Ivan D; Hwu WJ; Prieto VG; Torres-Cabala CA
    Am J Dermatopathol; 2020 May; 42(5):313-321. PubMed ID: 32310893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNA11-mutated and BAP1-negative Melanomas Ex Blue Naevi: A Particularly Aggressive Entity.
    Uguen A; Guibourg B; Costa S; Marcorelles P
    Acta Derm Venereol; 2017 Jun; 97(6):743-744. PubMed ID: 27990554
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
    Chan MP; Andea AA; Harms PW; Durham AB; Patel RM; Wang M; Robichaud P; Fisher GJ; Johnson TM; Fullen DR
    Mod Pathol; 2016 Mar; 29(3):227-39. PubMed ID: 26743478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
    Emley A; Nguyen LP; Yang S; Mahalingam M
    Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
    Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA
    Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.
    Mudhar HS; Doherty RE; Salvi SM; Currie ZI; Tan JH; Sisley K
    Ophthalmology; 2019 Jul; 126(7):1045-1052. PubMed ID: 30605742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.